Multidrug Resistant Pseudomonas Mycotic Pseudoaneurysm following Cardiac Transplant Bridged by Ventricular Assistant Device
Mycotic pseudoaneurysm of aorta following cardiac surgery is rare but is highly fatal if it is unrecognized and untreated. Here, we report a case of a 45-year-old male patient who presented with rapidly progressive multiple pseudoaneurysms of the ascending aorta infected with multidrug resistant (MD...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Case Reports in Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/2017/1402320 |
id |
doaj-5e8833f7e0dc454babe11591934cbe3d |
---|---|
record_format |
Article |
spelling |
doaj-5e8833f7e0dc454babe11591934cbe3d2020-11-24T23:15:29ZengHindawi LimitedCase Reports in Infectious Diseases2090-66252090-66332017-01-01201710.1155/2017/14023201402320Multidrug Resistant Pseudomonas Mycotic Pseudoaneurysm following Cardiac Transplant Bridged by Ventricular Assistant DeviceC. Aye0M. Williams1R. Horvath2Infection Management Unit, The Prince Charles Hospital, Brisbane, QLD 4032, AustraliaDepartment of Pharmacy, The Prince Charles Hospital, Brisbane, QLD 4032, AustraliaInfection Management Unit, The Prince Charles Hospital, Brisbane, QLD 4032, AustraliaMycotic pseudoaneurysm of aorta following cardiac surgery is rare but is highly fatal if it is unrecognized and untreated. Here, we report a case of a 45-year-old male patient who presented with rapidly progressive multiple pseudoaneurysms of the ascending aorta infected with multidrug resistant (MDR) Pseudomonas aeruginosa at 5 weeks after cardiac transplantation, on a background of prior bridging therapy with left ventricular assistant device (LVAD). The patient was successfully treated with the newer cephalosporin, Ceftolozane/Tazobactam, in combination with surgery. This is the first reported case of mycotic pseudoaneurysm infected with MDR Pseudomonas. This case also highlights the importance of high vigilance and timely multimodality treatment in the diagnosis and management of mycotic pseudoaneurysm following cardiac transplant, especially in patients who had LVAD.http://dx.doi.org/10.1155/2017/1402320 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
C. Aye M. Williams R. Horvath |
spellingShingle |
C. Aye M. Williams R. Horvath Multidrug Resistant Pseudomonas Mycotic Pseudoaneurysm following Cardiac Transplant Bridged by Ventricular Assistant Device Case Reports in Infectious Diseases |
author_facet |
C. Aye M. Williams R. Horvath |
author_sort |
C. Aye |
title |
Multidrug Resistant Pseudomonas Mycotic Pseudoaneurysm following Cardiac Transplant Bridged by Ventricular Assistant Device |
title_short |
Multidrug Resistant Pseudomonas Mycotic Pseudoaneurysm following Cardiac Transplant Bridged by Ventricular Assistant Device |
title_full |
Multidrug Resistant Pseudomonas Mycotic Pseudoaneurysm following Cardiac Transplant Bridged by Ventricular Assistant Device |
title_fullStr |
Multidrug Resistant Pseudomonas Mycotic Pseudoaneurysm following Cardiac Transplant Bridged by Ventricular Assistant Device |
title_full_unstemmed |
Multidrug Resistant Pseudomonas Mycotic Pseudoaneurysm following Cardiac Transplant Bridged by Ventricular Assistant Device |
title_sort |
multidrug resistant pseudomonas mycotic pseudoaneurysm following cardiac transplant bridged by ventricular assistant device |
publisher |
Hindawi Limited |
series |
Case Reports in Infectious Diseases |
issn |
2090-6625 2090-6633 |
publishDate |
2017-01-01 |
description |
Mycotic pseudoaneurysm of aorta following cardiac surgery is rare but is highly fatal if it is unrecognized and untreated. Here, we report a case of a 45-year-old male patient who presented with rapidly progressive multiple pseudoaneurysms of the ascending aorta infected with multidrug resistant (MDR) Pseudomonas aeruginosa at 5 weeks after cardiac transplantation, on a background of prior bridging therapy with left ventricular assistant device (LVAD). The patient was successfully treated with the newer cephalosporin, Ceftolozane/Tazobactam, in combination with surgery. This is the first reported case of mycotic pseudoaneurysm infected with MDR Pseudomonas. This case also highlights the importance of high vigilance and timely multimodality treatment in the diagnosis and management of mycotic pseudoaneurysm following cardiac transplant, especially in patients who had LVAD. |
url |
http://dx.doi.org/10.1155/2017/1402320 |
work_keys_str_mv |
AT caye multidrugresistantpseudomonasmycoticpseudoaneurysmfollowingcardiactransplantbridgedbyventricularassistantdevice AT mwilliams multidrugresistantpseudomonasmycoticpseudoaneurysmfollowingcardiactransplantbridgedbyventricularassistantdevice AT rhorvath multidrugresistantpseudomonasmycoticpseudoaneurysmfollowingcardiactransplantbridgedbyventricularassistantdevice |
_version_ |
1725590770612699136 |